Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.27B |
| 2 |
SNDK
Sandisk
SNDK
|
+$674M |
| 3 |
Credo Technology Group
CRDO
|
+$476M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$452M |
| 5 |
Vertiv
VRT
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.98B |
| 2 |
Amazon
AMZN
|
+$1.25B |
| 3 |
Shopify
SHOP
|
+$1.08B |
| 4 |
Edwards Lifesciences
EW
|
+$1.07B |
| 5 |
Microsoft
MSFT
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.11% |
| 2 | Communication Services | 13.94% |
| 3 | Consumer Discretionary | 10.64% |
| 4 | Industrials | 9.08% |
| 5 | Healthcare | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
126
PPL Corp
PPL
$25.7B
| $127M | 0.08% |
3,499,110
+1,195,128
| +52% | +$44.2M |
|
127
AstraZeneca
AZN
$252B
| $126M | 0.08% |
666,497
+2,552
| +0.4% | +$480K |
|
128
Comfort Systems
FIX
$53.5B
| $126M | 0.08% |
63,477
+33,590
| +112% | +$61M |
|
129
Rush Enterprises Class A
RUSHA
$8.27B
| $124M | 0.07% |
1,699,609
+578,159
| +52% | +$40.8M |
|
130
Nordson
NDSN
$18.1B
| $120M | 0.07% |
398,533
+10,423
| +3% | +$2.96M |
|
131
Applied Materials
AMAT
$366B
| $120M | 0.07% |
165,784
-126,503
| -43% | -$58.4M |
|
132
Hexcel
HXL
$7.17B
| $119M | 0.07% |
1,193,356
+9,040
| +0.8% | +$819K |
|
133
Gates Industrial Corp
GTES
$6.55B
| $118M | 0.07% |
4,228,443
+324,196
| +8% | +$8.33M |
|
134
Kirby Corp
KEX
$7.34B
| $118M | 0.07% |
865,097
+107,068
| +14% | +$15.3M |
|
135
Caterpillar
CAT
$368B
| $116M | 0.07% |
109,244
-20,662
| -16% | -$18.2M |
|
136
CMS Energy
CMS
$21.4B
| $116M | 0.07% |
1,517,533
-70,126
| -4% | -$5.26M |
|
137
Northrop Grumman
NOC
$77.5B
| $115M | 0.07% |
226,563
-108,502
| -32% | -$62.6M |
|
138
Ameris Bancorp
ABCB
$5.74B
| $115M | 0.07% |
1,274,893
-115,119
| -8% | -$9.79M |
|
139
RBC Bearings
RBC
$15.8B
| $114M | 0.07% |
176,861
-2,478
| -1% | -$1.48M |
|
|
MRSH
140
Marsh
MRSH
$91.9B
| $114M | 0.07% |
683,273
+460,679
| +207% | +$77M |
|
141
Danaher
DHR
$152B
| $114M | 0.07% |
597,780
+227,057
| +61% | +$41.2M |
|
142
AXIS Capital
AXS
$7.26B
| $114M | 0.07% |
1,057,270
-14,617
| -1% | -$1.47M |
|
143
PepsiCo
PEP
$193B
| $114M | 0.07% |
838,558
+309,429
| +58% | +$46.3M |
|
144
Rockwell Automation
ROK
$47.8B
| $113M | 0.07% |
228,111
-21,974
| -9% | -$9.56M |
|
145
Churchill Downs
CHDN
$6.27B
| $113M | 0.07% |
1,257,575
+122,857
| +11% | +$11M |
|
146
Valero Energy
VLO
$101B
| $113M | 0.07% |
432,725
+19,288
| +5% | +$4.75M |
|
|
WCC
147
WESCO International
WCC
$16.4B
| $111M | 0.07% |
322,583
+3,418
| +1% | +$1.16M |
|
148
Dorman Products
DORM
$3.84B
| $111M | 0.07% |
814,857
-11,428
| -1% | -$1.35M |
|
149
Elanco Animal Health
ELAN
$12B
| $111M | 0.07% |
4,508,395
+1,387,730
| +44% | +$32.1M |
|
150
Arcutis Biotherapeutics
ARQT
$2.99B
| $111M | 0.07% |
4,219,058
-761,712
| -15% | -$17.7M |
|
Similar funds
Jennison Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Jennison Associates held 641 positions worth $167B, up 15% from $145B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates withdrew a net $6.22B in Q2 2026, closing 74 positions and reducing 282 holdings. Its most notable exit was Gilead Sciences, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in SpaceX worth $1.27B.
- Jennison Associates's largest Q2 2026 buy was SpaceX: 7,448,891 shares worth $1.27B.
- Jennison Associates added most to Credo Technology Group in Q2 2026, an estimated $476M increase.
- Jennison Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.98B.
- Jennison Associates fully exited Gilead Sciences in Q2 2026, selling an estimated $176M.
- Jennison Associates's ten largest holdings make up 45% of its $167B portfolio in Q2 2026.
- Jennison Associates opened 79 new positions and closed 74 in Q2 2026.
- Jennison Associates's portfolio value rose 15% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.